Stay updated on Dupilumab for Eosinophilic Gastritis Clinical Trial
Sign up to get notified when there's something new on the Dupilumab for Eosinophilic Gastritis Clinical Trial page.

Latest updates to the Dupilumab for Eosinophilic Gastritis Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov record for the dupilumab eosinophilic gastritis study is available, with details on its design, eligibility, locations, outcomes, and supporting documents.SummaryDifference55%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedAn NIH-wide banner was added announcing updates about the agency’s terminology transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check31 days agoChange DetectedThe footer's site revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check38 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check51 days agoChange DetectedAccess to the NCT03678545 study record now shows a 403 Forbidden error, replacing the full trial content. This indicates an access restriction rather than a substantive update to the study data.SummaryDifference19%

Stay in the know with updates to Dupilumab for Eosinophilic Gastritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab for Eosinophilic Gastritis Clinical Trial page.